Biogen loses $18B in market value, pulls down the rest of biotech with it
July 24, 2015 at 14:28 PM EDT
The worst week in years for Biogen has cost the state’s most valuable company nearly $20 billion in market value, and appears to have dragged down the rest of publicly-traded biotech companies along with it...
